waivering on the issue? chief political correspondent candy crowley following it all. fda expected to soon decide the fate of a popular breast cancer drug. it's debating whether avastin should be approved for fighting the disease even though many women say it's helping them stay alive. so it's going to be two years with my daughter. and to me that's kind of priceless. >> smile big for mama. >> i mean, again, will willingly take whatever i can get to give me more time with my family. >> pulling its approval means insurance companies could stop paying for it. our elizabeth cohen looks at the debate and a woman's emotional plea to the fda. am fix blog is going on. please join us. cnn.com/amfix.